Catalyst Pharmaceuticals, Inc. (CPRX)
NASDAQ: CPRX · Real-Time Price · USD
23.23
-0.16 (-0.68%)
At close: Mar 13, 2026, 4:00 PM EDT
23.71
+0.48 (2.07%)
After-hours: Mar 13, 2026, 7:45 PM EDT
Catalyst Pharmaceuticals Employees
Catalyst Pharmaceuticals had 182 employees as of December 31, 2025. The number of employees increased by 1 or 0.55% compared to the previous year.
Employees
182
Change (1Y)
1
Growth (1Y)
0.55%
Revenue / Employee
$3,236,203
Profits / Employee
$1,177,615
Market Cap
2.84B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 182 | 1 | 0.55% |
| Dec 31, 2024 | 181 | 14 | 8.38% |
| Dec 31, 2023 | 167 | 85 | 103.66% |
| Dec 31, 2022 | 82 | 6 | 7.89% |
| Dec 31, 2021 | 76 | 2 | 2.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| Arcus Biosciences | 601 |
| Beam Therapeutics | 511 |
| Tarsus Pharmaceuticals | 370 |
| Arcutis Biotherapeutics | 354 |
| Dyne Therapeutics | 258 |
| Viridian Therapeutics | 252 |
| Vera Therapeutics | 249 |
CPRX News
- 4 days ago - Catalyst Pharmaceuticals, Inc. (CPRX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript - Seeking Alpha
- 9 days ago - Catalyst Pharmaceuticals to Showcase Real‑World Findings in Duchenne Muscular Dystrophy and Host Vamorolone-Focused Symposium at the 2026 MDA Clinical & Scientific Conference - GlobeNewsWire
- 16 days ago - Catalyst Pharmaceuticals, Inc. (CPRX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 17 days ago - Catalyst Pharmaceuticals Reports Record Fourth Quarter and Record Full Year 2025 Financial Results and Provides 2026 Financial Guidance - GlobeNewsWire
- 19 days ago - Catalyst Pharmaceuticals to Participate in the Barclays 28th Annual Global Healthcare Conference - GlobeNewsWire
- 24 days ago - Catalyst Pharmaceuticals: Clear Path Forward For Growth In 2 FDA-Approved Drugs - Seeking Alpha
- 4 weeks ago - Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026 - GlobeNewsWire
- 2 months ago - Catalyst Pharmaceuticals, Inc. (CPRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha